Showing results (821-830 of 991) with videos related to
Sort By:
Pageof 100
Biorxiv : the Preprint Server for Biology|June 12, 2025
Maternal Vitamin C Deficiency and Genetic Risk Factors Contribute to Congenital Defects through Dysregulation of DNA MethylationBernard K van der Veer, Colin Custers, Wannes Brangers, et al.Open Veterinary Journal|November 1, 2021
The potential anti-African swine fever virus effects of medium chain fatty acids on <i>in vitro</i> feed model: An evaluation study using epidemic ASFV strain circulating in VietnamHa Thi Thanh Tran, Anh Duc Truong, Duc Viet Ly, et al.Chimia|October 29, 2015
Scientific Basis for Regulatory Decision-Making of Nanomaterials Report on the Workshop, 20-21 January 2014, Center of Applied Ecotoxicology, DübendorfChristoph Studer, Lothar Aicher, Bojan Gasic, et al.Plos One|January 12, 2013
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinibMatthias Scheffler, Thomas Zander, Lucia Nogova, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinomaRichard Riedel, Sebastian Michels, Carina Heydt, et al.Swiss Medical Weekly|January 21, 2025
Advancements in lung cancer: a comprehensive perspective on diagnosis, staging, therapy and follow-up from the SAKK Working Group on Imaging in Diagnosis and Therapy MonitoringLisa Jungblut, Stefania Maria Rizzo, Lukas Ebner, et al.International Journal of Radiation Oncology, Biology, Physics|April 17, 2024
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study GroupJohannes Rosenbrock, Helen Kaul, Michael Oertel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in <i>EGFR</i>-Mutated Lung Cancer with Unknown Mechanism of Acquired ResistanceMartin Schuler, Jörg Hense, Kaid Darwiche, et al.Chimia|October 7, 2017
Scientific Basis for Regulatory Decision-Making of Nanomaterials Report on the Workshop, 20-21 January 2014, Center of Applied Ecotoxicology, DübendorfChristoph Studer, Lothar Aicher, Bojan Gasic, et al.Frontiers in Immunology|December 6, 2021
Structural Evolution of TIR-Domain SignalosomesSurekha Nimma, Weixi Gu, Natsumi Maruta, et al.Pageof 100